Author
Listed:
- Zameer Shervani
(Food & Energy Security Research & Product Centre, Japan)
- Deepali Bhardwaj
(Centre for Skin and Hair Pvt. Ltd., India)
- Roma Nikhat
(Food & Energy Security Research & Product Centre, Japan)
Abstract
The first and second serosurvey results of COVID-19 antibodies in Dharavi and Cuffe Parade slums (Mumbai, India) were studied. The seroprevalence data of the slums explained the zero novel coronavirus cases reported in the slum dwellers verified first in real on the ground the concept of much needed herd immunity against the pandemic. First serosurvey data showed that more than half (57%) of the population of Dharavi was infected with the virus. The antibodies were waned off in two month time and diminished to 45%, as found in the second survey conducted after two months of the first survey. The antibodies prevalence was highest at 75% in Cuffe Parade slums of Mumbai. Initially, Dharavi slums were a hotspot of novel coronavirus which later became nearly a no-new infection zone. The herd immunity acquired in Dharavi residents stopped the new infection. One million Dharavi slum dwellers living in a crowded semi-isolated cluster mimic the petri-dish model of a human population which is now a near COVID-19 free zone due to the presence of antibodies in the residents. The infection rate in Maharashtra, India, and Dharavi slums was compared. The concept of herd immunity that occurred on the ground in real has been first established. The research is very useful to vaccinate populations to eradicate the pandemic from the globe.
Suggested Citation
Zameer Shervani & Deepali Bhardwaj & Roma Nikhat, 2021.
"Dharavi Slums (Mumbai, India): The Petri Dish of COVID-19 Herd Immunity,"
European Journal of Medical and Health Sciences, European Open Science, vol. 3(3), pages 38-41, May.
Handle:
RePEc:epw:ejmed0:v:3:y:2021:i:3:id:40860
DOI: 10.24018/ejmed.2021.3.3.860
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:3:y:2021:i:3:id:40860. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.